Area of research
Psychiatry and Mental health · Pharmacology
Research interest
Research interests include Medicine, Placebo, Disease, Tolerability, Citalopram, and Adverse effect.
Valacyclovir Treatment of Early Symptomatic Alzheimer Disease
Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial
Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study design
Effect of Citalopram on Agitation in Alzheimer Disease
Relapse Risk after Discontinuation of Risperidone in Alzheimer's Disease